Atlas FDA

Onyx Liquid Embolic System

FDA premarket approval P030004/S025 · decided 2020-11-13

Approval details

PMA number
P030004
Supplement
S025
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Onyx Liquid Embolic System
Generic name
Agent, injectable, embolic
Applicant
Ev3 Neurovascular
Date received
2020-10-19
Decision date
2020-11-13
Days to decision
25 days
Decision code
OK30
Product code
MFE
Advisory committee
Neurology
Expedited review
No
Location
Irvine, CA
Statement
Manufacturing location of the supplier of EVOH (ethylene vinyl alcohol) for Onyx Liquid Embolic System from Japan to Belgium to increase the production capacity.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
MERIDIAN GUIDEWIRE (K093681)Ev3 Neurovascular2010-01-26
HYPERGLIDE OCCLUSION BALLOON SYSTEM, HYPERFORM OCCLUSION BALLOON SYSTEM, MODEL 104-4112, 104-4113, 104-4127,104-4132,104 (K091458)Ev3 Neurovascular2009-10-15
HYPERGLIDE OCCLUSION BALLOON SYSTEM, MODEL 104-4310, 104-4315 (K092495)Ev3 Neurovascular2009-09-22